Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects
NCT01210352
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
61
Enrollment
INDUSTRY
Sponsor class
Conditions
Post Operative Pain
Interventions
DRUG:
oxymorphone HCl
Sponsor
Endo Pharmaceuticals